ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA04 | G | Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg | 7676 | 30714/1 | GIZLAN-PLUS | 30 | Tablet, film coated | Oral | Sadco | Dar Al Dawa Development & Investment Co Ltd | Jordan | 395,090 L.L | 23.08 | A1 | Dar Al Dawa Development & Investment Co Ltd | Jordan | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA04 | B | Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg | 10873 | 27322/1 | CO APROVEL | 28 | Tablet, film coated | Oral | Mersaco | Sanofi Winthrop Industrie | France | 658,483 L.L | 23.08 | A1 | Sanofi Aventis Groupe | France | 12/12/20 | 0 | |
C09DA04 | G | Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg | 10529 | 130417/1 | CONVERIUM PLUS | 30 | Tablet, film coated | Oral | New Allpharma | Medochemie Ltd | Cyprus | 395,090 L.L | 23.08 | A1 | Medochemie Ltd | Cyprus | 12/12/20 | 0 | |
C09DA04 | G | Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg | 6225 | 167547/10 | ZIOREL PLUS | 30 | Tablet, film coated | Oral | Droguerie de l'Union | Algorithm S.A.L. | Lebanon | 559,294 L.L | 23.08 | A1 | 12/12/20 | 0 | |||
C09DA04 | G | Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg | 7386 | 185988/13 | ANDARAN PLUS | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Pharmaline (Packing) under license from Sandoz, Austria | Lebanon | 544,586 L.L | 23.08 | A1 | 12/12/20 | 0 | |||
C09DA04 | G | Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg | 8513 | 185802/13 | IBECARD PLUS 300/12.5 | 30 | Tablet, film coated | Oral | IPS "Integrated Pharma Solutions SARL" | Benta SAL | Lebanon | 559,294 L.L | 23.08 | A1 | 12/12/20 | 0 | |||
C09DA04 | G | Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg | 10589 | 17621/1 | IRBAVEL PLUS 300/12.5 | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 559,294 L.L | 23.08 | A1 | 12/12/20 | 0 |